Updates are available Correction dated 2022-03-07
Click to view Correction: https://doi.org/10.1038/s41575-022-00597-8
-
Authors
Verstockt, Bram http://orcid.org/0000-0003-3898-7093
Vetrano, Stefania
Salas, Azucena http://orcid.org/0000-0003-4572-2907
Nayeri, Shadi
Duijvestein, Marjolijn http://orcid.org/0000-0003-4814-9376
Vande Casteele, Niels http://orcid.org/0000-0003-0854-0274
Danese, Silvio
D’Haens, Geert
Eckmann, Lars
Faubion, William A.
Feagan, Brian G.
Jairath, Vipul
Ma, Christopher
McGovern, Dermot
Panes, Julian
Sandborn, William J.
Silverberg, Mark S.
Vermeire, Severine
,
- License Information
-
More Information
Article History
Accepted: 22 December 2021
First Online: 14 February 2022
Change Date: 7 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41575-022-00597-8
Competing interests
: B.V. reports financial support for research from Pfizer; lecture fees from Abbvie, Biogen, Chiesi, Falk, Ferring, Galapagos, Janssen, MSD, Pfizer, R-Biopharm, Takeda and Truvion; and consultancy fees from Janssen, Guidepont and Sandoz; these activities were all outside of the submitted work. A.S. reports research grants from Roche-Genentech, Abbvie, GSK, Scipher Medicine, Alimentiv (formerly Robarts Clinical Trials) and Boehringer Ingelheim and consulting fees from Genentech, GSK, Pfizer, HotSpot Therapeutics, Surrozen, and Morphic Therapeutic. M.D. reports advisory fees from Echo Pharma and Alimentiv (formerly Robarts Clinical Trials); speaker fees from Janssen, Merck & Co., Pfizer, Takeda and Tillotts Pharma; and non-financial support from Dr. Falk Pharm; these activities were all outside of the submitted work. N.V.C. reports research grants and personal fees from R-Biopharm, Takeda, and UCB and personal fees from Alimentiv (formerly Robarts Clinical Trials), Celltrion and Prometheus; these activities were all outside of the submitted work. N.V.C. holds a Research Scholar Award from the American Gastroenterological Association and this project was, in part, supported by the Digestive Diseases Research Center grant NIH DK120515. Alimentiv (formerly Robarts Clinical Trials) is an academic gastrointestinal contract research organization (CRO), operating under the Alimentiv Health Trust. Alimentiv provides centralized imaging management solutions in clinical trials, including endoscopy, histopathology and magnetic resonance imaging. Alimentiv provides full service CRO capabilities as well as precision medicine services. A.S., M.D. and N.V.C. as well as Alimentiv Translational Research Consortium Member Authors listed in Supplementary BoxInternalRef removed, including G.D’H., B.G.F., V.J., C.M. and W.J.S., are consultants, and have neither equity positions nor shares in the corporation. The other authors declare no competing interests.
